TC
WST icon

TwinBeech Capital’s West Pharmaceutical WST Stock Holding History

TwinBeech Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-93,892
Closed -$33.1M – 895
2023
Q4 		$33.1M Buy
+93,892
New +$33.2M 0.53% 48
2023
Q1 		– Sell
-3,592
Closed -$845K – 926
2022
Q4 		$845K Sell
3,592
-78,834
-96% -$18.7M 0.02% 533
2022
Q3 		$20.3M Buy
82,426
+49,730
+152% +$15.1M 0.54% 51
2022
Q2 		$9.89M Buy
+32,696
New +$10.6M 0.44% 68
2020
Q4 		– Sell
-14,783
Closed -$4.06M – 644
2020
Q3 		$4.06M Buy
+14,783
New +$3.91M 0.88% 19

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

TwinBeech Capital's WST Position: Q1 2024 in Review

TwinBeech Capital sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 93,892 shares — an estimated $33.1M sold.

TwinBeech Capital first reported a position in WST in Q3 2020 and held it in 5 quarters. The position peaked at $33.1M in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • TwinBeech Capital reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • TwinBeech Capital sold 93,892 West Pharmaceutical shares in Q1 2024, an estimated $33.1M.
  • TwinBeech Capital first reported a position in West Pharmaceutical in Q3 2020 and held it in 5 quarters.
  • TwinBeech Capital's West Pharmaceutical position peaked at $33.1M in Q4 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on TwinBeech Capital's 13F filing for Q1 2024, filed 15 May 2024.